Yesterday, according to report, California-based longevity skincare brand Oneskin has announced a $20 million investment from growth equity firm Prelude Growth Partners. The funding, which replaces a previous investor without diluting any existing shareholders, marks a significant milestone for the brand as it gears up for its next phase of growth.
Founded in 2021 by four Brazilian scientists, Oneskin is known for its proprietary peptide OS-01, which the company claims delivers unique anti-aging benefits. The brand offers facial, body, and hair care products, primarily sold through its e-commerce platform and Amazon. Subscriptions account for more than two-thirds of its business, according to CEO Carolina Reis Oliveira.
Prelude Growth Partners, whose beauty portfolio includes Sol de Janeiro, Summer Fridays, and Tower28, approached Oneskin with a strategic proposal that impressed the brand’s leadership. “[Prelude] would bring up our blind spots in a way that others were not,” said Reis Oliveira, noting that the firm provided valuable input on revenue forecasting and long-term planning. A source close to the company revealed that Oneskin is on track to generate $40–$50 million in revenue this year.
The new capital will support a brand refresh, expanded clinical trials, and key hires, including a head of brand and chief marketing officer. Recent additions to the team include a vice president of growth marketing and a creative director. While Oneskin is currently focused on direct-to-consumer sales, it is considering a potential retail entry in 2027 and plans to invest further in product development and marketing.
Reis Oliveira emphasized that the company is in a strong financial position and has no immediate plans for additional fundraising. The Prelude deal, she said, provides both strategic alignment and financial flexibility as Oneskin continues to scale.
